Hemosphere
3 known investors
HeRO Graft is a fully subcutaneous arteriovenous access device for hemodialysis patients with central venous stenosis, designed to reduce infection rates and improve long-term vascular access reliability. The product combines an ePTFE arterial graft component with a silicone venous outflow component for dialysis treatment.
Investors · 3
In the news
Frequently asked questions
- What does Hemosphere do?
- HeRO Graft is a fully subcutaneous arteriovenous access device for hemodialysis patients with central venous stenosis, designed to reduce infection rates and improve long-term vascular access reliability. The product combines an ePTFE arterial graft component with a silicone venous outflow component for dialysis treatment.
- Who are Hemosphere's investors?
- Hemosphere's investors include Emergent Medical Partners, LLP, Mutual Capital Partners, Kaiser Permanente Ventures.